DBV Technologies S.A. (DBVT)

Name: DBV Technologies S.A. (DBVT) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Also trades as DBVTF. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001613780 · Nasdaq · Biological Products, (No Diagnostic Substances)

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, DBV Technologies S.A. reported revenue of $5.64M. Revenue grew 35.8% from the prior annual period.

Key ratios (year ended 2025-12-31)

n/m

Operating margin

n/m

Net margin

-87.1%

Return on year-end equity

35.8%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-30

Headquarters locality: Bagneux · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Revenue	$5.64M	$4.15M	$15.73M	$4.84M	$5.71M	$11.28M	$14.71M
R&D Expense	$116.68M	$89.34M	$60.22M	$75.54M	$70.34M	$101.61M	$115.10M
Operating Income	-$147.06M	-$116.59M	-$76.43M	-$96.63M	-$98.61M	-$158.84M	-$171.02M
Depreciation & Amortization	$2.99M	$2.72M	$3.57M	n/a	n/a	n/a	n/a
EBITDA	-$144.07M	-$113.87M	-$72.87M	n/a	n/a	n/a	n/a
Net Income	-$146.95M	-$113.92M	$72.71M	$96.27M	-$97.81M	-$159.56M	-$172.01M
EPS (Diluted)	-$1.05	-$1.17	-$0.76	-$1.24	-$1.78	n/a	n/a
Total Assets	$233.72M	$65.66M	$182.99M	$246.52M	$146.72M	$272.25M	$271.73M
Total Liabilities	$64.95M	$38.27M	$42.80M	$52.06M	$47.45M	$66.75M	$78.54M
Long-Term Debt	n/a	n/a	n/a	n/a	$510.0K	$1.27M	$1.46M
Shareholders' Equity	$168.77M	$27.39M	$140.19M	$194.45M	$99.27M	$205.49M	$193.19M
Cash & Equivalents	$194.17M	$32.46M	$141.37M	$209.19M	$77.30M	$196.35M	$193.25M
Operating Cash Flow	-$121.18M	-$104.47M	-$79.65M	-$55.67M	-$108.24M	-$165.61M	-$148.35M
Capital Expenditures	$532.0K	$2.34M	$677.0K	$754.0K	$910.0K	$2.79M	$5.57M
Free Cash Flow	-$121.71M	-$106.81M	-$80.33M	-$56.42M	-$109.15M	-$168.40M	-$153.91M
Shares Outstanding	n/a	102.85M	n/a	n/a	n/a	n/a	n/a
Weighted Average Diluted Shares	139.57M	97.00M	95.12M	77.38M	54.92M	n/a	n/a
EPS (Basic)	-$1.05	-$1.17	-$0.76	-$1.24	-$1.78	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView